INNOVATIVE TECHNOLOGY IN TREATMENT OF TEMPOROMANDIBULAR DISORDERS
DOI:
https://doi.org/10.35220/2523-420X/2025.3.27Keywords:
temporomandibular joint, platelet-rich plasma, mesenchymal stem cells, low-level laser therapy, transcutaneous electrical nerve stimulation, extracorporeal shockwave therapy, digital technologiesAbstract
Introduction. Recent decades have been marked by the active implementation of high-tech methods in dental practice, fundamentally transforming approaches to the diagnosis and treatment of temporomandibular joint disorders. Among the leading directions, particular attention is drawn to digital technologies, bioengineering approaches to tissue regeneration, and the use of bioactive agents. Aim of the study. To summarize current data from scientific literature on innovative technologies used in the treatment of temporomandibular joint disorders and to determine their clinical effectiveness, safety, and prospects for further development. Materials and methods. An analytical review of domestic and international scientific and medical sources dedicated to novel technologies for temporomandibular joint pathology treatment was carried out. Results. An important direction in temporomandibular joint disorder management is the use of bioactive agents: platelet-rich plasma injections promote the regeneration of cartilage and synovial tissues due to growth factors; mesenchymal stem cells and their exosomes demonstrate significant regenerative potential. Physiotherapeutic methods, such as low-level laser therapy, extracorporeal shockwave therapy, and transcutaneous electrical nerve stimulation, have proven effective in pain reduction, decreasing muscle hypertonicity, and improving microcirculation. Occlusal therapy using individualized splints also plays a key role in comprehensive treatment.The implementation of CAD/CAM technologies and 3D printing has significantly increased the precision of appliance fabrication and patient comfort, which positively impacts clinical outcomes. Conclusions. Innovative technologies are shaping a new standard for the treatment of temporomandibular joint dysfunctions.Their application not only alleviates symptoms and inflammatory manifestations but also restores functional joint activity, thereby significantly improving patients’ quality of life. Further research in this area will contribute to the standardization of techniques and the optimization of clinical protocols.
References
Боян А.М., Іваненко О.В., Петренко С.М. Оклюзійні шини для лікування м’язово-суглобової дис-функції. Основи конструювання. Харківський стоматологічний журнал. 2024. Т. 1. № 1(1). С. 74–82. DOI: 10.26565/3083-5607-2024-1-08.
Ковалюк А.В., Ожоган З.Р. Ефективність застосування індивідуальної знімної шини-капи з метою коригування ступеня зубощелепних деформацій у хворих з дефектами зубних рядів. Галицький лікарський вісник. 2017. Т. 24. № 2. С. 18–21. DOI: 10.21802/gmj.2017.2.6.
Костюк Т.М., Канюра О.А. Ефективність лікування пацієнтів із м’язово-суглобовою дисфункцією скронево-нижньощелепних суглобів. Медицина сьогодні і завтра. Стоматологія. 2020. № 1 (86). С. 94–102. DOI: 10.35339/msz.2020.86.01.12.
Ожоган Р.З., Рожко М.М., Ожоган З.Р. Сучасні методи діагностики і лікування хворих із дефектами зубних рядів, ускладненими розладами скронево-нижньощелепного суглоба. Український стоматологічний альманах. 2017. № 1. С. 37 – 41.
Потапчук А.М., Русин В.В., Рівіс О.Ю. Фізіотерапевтичні технології в стоматології: навчальний посібник. Ужгород: ДВНЗ «УжНУ», 2022. C. 377 URL: https://drive.google.com/file/d/1n_At0tz-mFz11Oh7chcfcdc8DB1lijKl/view?usp=sharing (дата звернення: 20.10.2025).
Muñoz-Lora V.R.M., Dugonjić Okroša A., Matak I., Del Bel Cury A.A., Kalinichev M., Lacković Z. Antinociceptive actions of botulinum toxin A1 on immunogenic hypersensitivity in temporomandibular joint of rats. Toxins (Basel). 2022. Vol. 14. № 3. Article 161. DOI: 10.3390/toxins14030161.
Jia X., Jing S., Sun Y., Gong Z. A randomized controlled clinical trial of concentrated growth factor combined with sodium hyaluronate in the treatment of temporomandibular joint osteoarthritis. BMC Oral Health. 2024. Vol. 24. № 1. Article 540. DOI: 10.1186/ s12903-024-04258-x.
Antoniazzi C., Belinskaia M., Zurawski T., Kaza S.K., Dolly J.O., Lawrence G.W. Botulinum neurotoxin chimeras suppress stimulation by capsaicin of rat trigeminal sensory neurons in vivo and in vitro. Toxins (Basel). 2022. Vol. 14. № 2. Article 116. DOI: 10.3390/toxins14020116.
Bron C., Dommerholt J.D. Etiology of Myofascial Trigger Points. Current pain and headache reports. 2012. Vol. 16. № 5. P. 439 – 444. DOI: 10.1007/s11916-012-0289-4.
Tunç S.K., Değirmenci B.Ü., Bilen M., et al. Can extracorporeal shock wave therapy be effective in temporomandibular joint disorder?: A pilot study. Medicine. 2024. Vol. 103. № 43. Article ID e40052:3355. DOI: 10.1097/MD.0000000000040052.
Qin H., Liu Y., Miao H., et al. Comparative efficacy of digital 3D-printed and conventional stable occlusal splints in the treatment of temporomandibular disorders. Journal of oral rehabilitation. 2025. Vol. 52. № 10. P. 1699-1706 DOI: 10.1111/joor.14032.
Aktürk S., Kaya A., Çetintaş D., et al. Comparison of the effectiveness of ESWT and ultrasound treatments in myofascial pain syndrome: randomized, sham-controlled study. Journal of physical therapy science. 2018. Vol. 32. № 30. P. 448-453. DOI: 10.1589/jpts.30.448.
Derwich M., Mitus-Kenig M., Pawlowska E. Interdisciplinary approach to the temporomandibular joint osteoarthritis: review of the literature. Medicina (Kaunas). 2020. Vol. 56. № 5. Article 225. DOI: 10.3390/ medicina56050225.
De Oliveira D.W.D., Lages F.S., Guimarães R.C., et al. Do TMJ symptoms improve and last across time after treatment with red (660 nm) and infrared (790 nm) low-level laser treatment (LLLT)? A survival analysis. Cranio. 2017. Vol. 35. № 6. P. 372-378. DOI: 10.1080/08869634.2017.1292176.
De la Torre C.G., Poluha R.L., Alvarez Pinzón Y.N. Effects of botulinum toxin type A on the psychosocial features of myofascial pain TMD subjects: a randomized controlled trial. Journal of oral & facial pain and headache. 2021. Vol. 35. № 4. P. 288-296. DOI: 10.11607/ofph.2917.
Chen J., Huang Z., Ge M., Gao M. Efficacy of low-level laser therapy in the treatment of TMDs: a meta-analysis of 14 randomised controlled trials. Journal of oral rehabilitation. 2015. Vol. 42. № 4. P. 291-299. DOI: 10.1111/joor.12258.
Johnson J.F., Ronald J. Riegel, John C. Godbold Jr. Laser therapy and pain management. Laser therapy in veterinary medicine: photobiomodulation. Wiley-Blackwell [Ed.] 2017. 512 p.
Herranz-Aparicio J., Arnabat-Dominguez J., España-Tost A. Systematic review of low-level laser therapy in the treatment of temporomandibular disorders. Lasers in medical science. 2022. Vol. 37. № 1. P. 93-203.
Bergeron-Vézina K., Corriveau H., Martel M., et al. High- and low-frequency transcutaneous electrical nerve stimulation does not reduce experimental pain in elderly individuals. Pain. 2015. Vol. 156. № 10. P. 2093-2099. DOI: 10.1097/j.pain.0000000000000276.
Hussein A.H., Diaa A.E.S., Doaa T.H. Efficacy of digitally fabricated occlusal splints for treatment of temporomandibular disorders: a randomized controlled trial. Ain shams dental journal. 2025. Vol. 37. № 1. P. 409-418. DOI: 10.21608/ASDJ.2025.355809.1822.
Li J., Chen H. Intra-articular injection of platelet- rich plasma vs hyaluronic acid as an adjunct to TMJ arthrocentesis: a systematic review and meta-analysis. Journal of stomatology, oral and maxillofacial surgery. 2024. Vol. 125. № 2. Article ID: 101676. DOI: 10.1016/j. jormas.2023.101676.
McGoldrick D., Stassen L. Management of acute dislocation of the temporomandibular joint in dental practice. Journal of the Irish dental association. 2010. Vol. 56. № 6. P. 268-270.
Desai Mehul J., Saini V., Shawnjeet S. Myofascial pain syndrome: a treatment review. Pain therapy. 2013. Vol. 2. № 1. P. 21-36. DOI:v10.1007/s40122-013-0006-y.
Jiang Y., Shi J., Di W., et al. Mesenchymal stem cells and their exosomes for temporomandibular joint disorders: a systematic review of preclinical studies. Stem cell reviews and reports. 2022. Vol. 18. № 2. P. 711-723. DOI: 10.1007/s12015-021-10288-7.
Lippi L., de Sire A., Folli A., et al. Multidimensional effectiveness of botulinum toxin in neuropathic pain: a systematic review of randomized clinical trials. Toxins (Basel). 2022. Vol. 14. № 5. Article 308. DOI: 10.3390/ toxins14050308.
Murphy M.K., Arzi B., Prouty S.M., et al. Neocartilage integration in temporomandibular joint discs: physical and enzymatic methods. Journal of the royal society interface. 2015. Vol. 12. № 103. P. 1-9. DOI: 10.1098/rsif.2014.1075.
Nitecka-Buchta A., Walczyńska-Dragon K., Kempa W.M. Platelet-rich plasma (PRP) injections as an effective treatment for temporomandibular joint disorders: a clinical trial. Medical science monitoring. 2020. Vol. 26. Article 923189. DOI: 10.12659/MSM.923189.
Hegab A.F., Ali H.E., Elmasry M., Khallaf M.G. Platelet-rich plasma injection as an effective treatment for temporomandibular joint osteoarthritis. Journal of oral and maxillofacial surgery. 2015. Vol. 73. № 9. P. 706-713. DOI: 10.1016/j.joms.2015.03.045.
Ye N., Wu T., Dong T., et al. Precision of 3D-printed splints with different dental model offsets. American journal of orthodontics and dentofacial orthopedics official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics. 2019. Vol. 155. № 5. P. 733-738. DOI: 10.1016/j.ajodo.2018.09.012.
Rebekah R., Navaneethan R., Nagachandran K.S. Effect of transcutaneous electrical nerve stimulation therapy on condylar position and myofascial pain in patients with temporomandibular joint disorders–a pilot clinical trial. Journal of orthodontic science. 2024. Vol. 17. № 13. Article 36. DOI: 10.4103/jos.jos_21_24.
Scrivani S.J., Keith D.A., Kaban L.B. Temporomandibular disorders. The New England journal of medicine. 2008. Vol. 359. № 25. P. 2693-2705. DOI: 10.1056/NEJMra0802472.
Ferreira A.P., Alves da Costa D.R., de Oliveira A.I., et al. Short-term transcutaneous electrical nerve stimulation reduces pain and improves the masticatory muscle activity in temporomandibular disorder patients: a randomized controlled trial. Journal of applied oral science : revista FOB. 2017. Vol. 25. № 2. P. 112-120. DOI: 10.1590/1678-77572016-0173.
Slade G.D., Fillingim R.B., Sanders A.E., et al. Summary of findings from the OPPERA prospective cohort study of incidence of first-onset temporomandibular disorder: implications and future directions. Journal of pain. 2013. Vol. 14. 12 Suppl. P. T116-T124. DOI: 10.1016/j.jpain.2013.09.010.
Jeon J.H., Jung Y.J., Lee J.Y., et al. The effect of extracorporeal shock wave therapy on myofascial pain syndrome. Annals of rehabilitation medicine. 2012. Vol. 36. № 5. P. 665-674. DOI: 10.5535/arm.2012.36.5.665.
Kim H., Yang G., Park J. Therapeutic effect of mesenchymal stem cells derived from human umbilical cord in rabbit temporomandibular joint model of osteoarthritis. Scientific reports. 2019. Vol. 9. № 1. Article 13854. DOI: 10.1038/s41598-019-50435-2.
Somogyi A., Végh D., Róth I. Therapy for temporomandibular disorders: 3D-printed splints from planning to evaluation. Dentistry journal (Basel). 2023. Vol. 11. № 5. Article 126. DOI: 10.3390/dj11050126.
Mummolo S., Nota A., Tecco S., et al. Ultra-low-frequency transcutaneous electric nerve stimulation (ULF- TENS) in subjects with craniofacial pain: a retrospective study. Cranio. 2020. Vol. 38. № 6. P. 396-401. DOI: 10.1080/08869634.2018.1526849.
Vance C.G., Dailey D.L., Rakel B.A., Sluka K.A. Using TENS for pain control: the state of the evidence. Pain managment. 2014. Vol. 4. № 3. P. 197-209. DOI: 10.2217/pmt.14.13.
Wright E.F. Manual of temporomandibular disorders. 2nd edition. Ames (IA, USA): Wiley-Blackwell. 2009. P. 328.
Zonnenberg A.J., Mulder J. The efficacy of a specific stabilization splint. Cranio. 2014. Vol. 32. № 1. P. 68-74. DOI: 10.1179/0886963413Z.0000000008.
